ADRX NASDAQ
ADARx Pharmaceuticals, Inc.
1W: -5.7%
YTD: -5.7%
$18.25
-1.29 (-6.60%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
No convergence signal
Key Statistics
Market Cap$1.9B
52W Range—
Volume936,952
Avg Volume1,693,898
Beta0.00
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOZhen Li
SectorIndustrials
IndustrySpecialty Business Services
IPO Date2026-09-25
Websiteadarx.com
5871 Oberlin Drive, Suite 200
San Diego, CA 92121
US
San Diego, CA 92121
US
About ADARx Pharmaceuticals, Inc.
ADARx Pharmaceuticals, Inc. is a late-clinical-stage biotechnology company. It focuses on developing next-generation small interfering RNA (siRNA) therapeutics for diseases with significant unmet medical needs. The company was founded by Zhen Li in December 2019 and is headquartered in San Diego, CA.
Recent Insider Trades
No insider trades found